198 Saposin-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Hydrocarbons | 1 | 0.1 | 15× | not tested | |
| Lipids and lipid-like molecules | 6 | 1.1 | 5.46× | not tested | |
| Organic oxygen compounds | 3 | 2.0 | 1.53× | not tested | |
| Benzenoids | 1 | 0.7 | 1.39× | not tested | |
| Organoheterocyclic compounds | 2 | 1.5 | 1.32× | not tested | |
| Homogeneous metal compounds | 3 | 4.8 | 0.62× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 8 |
| DB04327 | PEE | Phosphatidylethanolamine | 8 |
| DB02767 | FTT | (R)-3-hydroxytetradecanoic acid | 7 |
| DB08231 | MYR | Myristic acid | 4 |
| DB00608 | CLQ | Chloroquine | 3 |
| DB01117 | AOQ | Atovaquone | 3 |
| DB02515 | G3P | sn-glycerol 3-phosphate | 1 |
| DB03017 | DAO | Lauric acid | 1 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 1 |
| DB03796 | PLM | Palmitic Acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| RXY | (7Z,19R,22R)-25-amino-22-hydroxy-16,22-dioxo-17,21,23-trioxa-22lambda~5~-phosphapentacos-7-en-19-yl (9Z)-octadec-9-enoate | 12 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 8 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 8 |
| FTT | 3-HYDROXY-TETRADECANOIC ACID | 7 |
| MYR | MYRISTIC ACID | 4 |
| AOQ | 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione | 3 |
| CLQ | N4-(7-CHLORO-QUINOLIN-4-YL)-N1,N1-DIETHYL-PENTANE-1,4-DIAMINE | 3 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 2 |
| D10 | DECANE | 2 |
| FAW | (2S)-3-hydroxypropane-1,2-diyl ditetradecanoate | 2 |
| G3P | SN-GLYCEROL-3-PHOSPHATE | 2 |
| ZNmetal | ZINC ION | 2 |
| CAmetal | CALCIUM ION | 1 |
| DAO | LAURIC ACID | 1 |
| MPO | 3[N-MORPHOLINO]PROPANE SULFONIC ACID | 1 |
| PLM | PALMITIC ACID | 1 |
| PX8 | 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHATE | 1 |